Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 1—January 2017
Research

Estimated Incidence of Antimicrobial Drug–Resistant Nontyphoidal Salmonella Infections, United States, 2004–2012

Felicita MedallaComments to Author , Weidong Gu, Barbara Mahon, Michael Judd, Jason P. Folster, Patricia M. Griffin, and Robert M. Hoekstra
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Nontyphoidal Salmonella isolates with clinically important resistance, by serotype and resistance category, United States, 2004–2012*

Resistance category Typhimurium, no. (%), 
n = 3,324 Enteritidis, no. (%), 
n = 3,501 Newport, no. (%), 
n = 2,175 Heidelberg, no. (%), 
n = 738 Other fully serotyped, 
no. (%), n = 9,265 Not fully serotyped, 
no. (%), n = 407 Total NTS, no. (%), 
n = 19,410
Cipro† 54 (1.6) 211 (6.0) 7 (0.3) 2 (0.3) 183 (2.0) 10 (2.5) 467 (2.4)
Cef/Amp‡ 162 (4.9) 8 (0.2) 198 (9.1) 87 (11.8) 141 (1.5) 3 (0.7) 599 (3.1)
Amp-only§ 750 (22.6) 90 (2.6) 25 (1.1) 94 (12.7) 274 (3.0) 21 (5.2) 1,254 (6.5)
Any of the above¶ 966 (29.1) 309 (8.8) 230 (10.6) 183 (24.8) 598 (6.5) 34 (8.4) 2,320 (12.0)

*Total NTS isolates include isolates serotyped as Typhimurium, Enteritidis, Newport, and Heidelberg; isolates serotyped as other than these 4; and those not fully serotyped. Amp-only, resistant to ampicillin but susceptible to ceftriaxone and ciprofloxacin; Cef/Amp, resistant to ceftriaxone and ampicillin; Cipro, nonsusceptible to ciprofloxacin but susceptible to ceftriaxone; NTS, nontyphoidal Salmonella. Cipro, Cef/Amp, and Amp-only are mutually exclusive categories.
†Nonsusceptible to ciprofloxacin (MIC >0.12 μg/mL) but susceptible to ceftriaxone, with or without resistance to other agents.
‡Resistant to ceftriaxone (MIC ≥4 μg /mL) and ampicillin (MIC ≥32 μg /mL), with or without nonsusceptibility to ciprofloxacin or resistance to other agents; of the 599 ceftriaxone-resistant isolates, 38 (0.2% of all NTS isolates) were nonsusceptible to ciprofloxacin.
§Resistant to ampicillin but susceptible to ceftriaxone and ciprofloxacin, with or without resistance to other agents.
¶Nonsusceptible to ciprofloxacin, resistant to ceftriaxone, or resistant to ampicillin.

Main Article

Page created: December 14, 2016
Page updated: December 14, 2016
Page reviewed: December 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external